Modulation of ornithine decarboxylase activity and mitogen-activated protein kinases in protocatechualdehyde-induced apoptosis of CTLL-2 cells

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3389-3394

  Wang, Yinna ^a,b   Zhu, Zhenyu ^b   Hasuma, Tadayoshi ^a   Yano, Yoshihisa ^a   Morishima, Yoshihiro ^a   Matsui Yuasa, Isao ^c   Otani, Shuzo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUN YAT SEN UNIVERSITY   (China)

^c Osaka Prefecture University   (Japan)

Author keywords

Apoptosis; MAP kinases; ODC activity; Proto catechualdehyde

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; ORNITHINE DECARBOXYLASE; PROTOCATECHUALDEHYDE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BENZALDEHYDES; CATECHOLS; CELL DIVISION; CELL LINE; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; INTERLEUKIN-2; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; ORNITHINE DECARBOXYLASE; PHOSPHORYLATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036871208     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Tabor CW and Tabor H: Polyamines. Annu Rev Biochem 53: 749-90, 1984.
2. Janne J, Alhonen L and Leinonen P: Polyamines: from molecular biology to clinical applications. Ann Med 23(3): 241-59, 1991.
3. Grillo MA: Metabolism and function of polyamines. Int J Biochem 17(9): 943-8, 1985.
4. Gilmour SK, Robertson FM, Megosh L, O'Connell SM, Mitchell J and O'Brien TG: Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate. Carcinogenesis 13(1): 51-6, 1992.
5. Kim YJ, Pan H and Verma AK: Non-AP-1 tumor promoter 12-O-tetradecanoylphorbol-13-acetate responsive sequences in the human ornithine decarboxylase gene. Mol Carcinog 10(3): 169-79, 1992.
6. Amori A, Nishiguchi S, Kuroki T, Seki S, Kobayashi K, Kinoshita H and Otani S: Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma. Hepatology 20(5): 1179-86, 1994.
7. Hibshoosh H, Johnson M and Weinstein IB: Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. Oncogene 6(5): 739-43, 1991.
8. McCann PP and Pegg AE: Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther 54(2): 195-215, 1992.
9. Pegg AE, Shantz LM and Coleman CS: Ornithine decarboxylase as a target for chemoprevention. J Cell Biochem Suppl 22: 132-8, 1995.
10. Eyskens FL Jr and Gerner EW: Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 5(5): 945-51, 1999.
11. Widmann C, Gibson S, Jarpe MB and Johnson GL: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79(1): 143-80, 1999.
12. Karin M: Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Biol 6(3): 415-24, 1994.
13. Seger R and Krebs EG: The MAPK signaling cascade. Faseb J 9(9): 726-35, 1995.
14. Parrizas M, Saltiel AR and LeRoith D: Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272(1): 154-61, 1997.
15. Villalba M, Bockaert J and Journot L: Pituitary adenylate cyclase-activating polypeptide (PACAP 38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17(1): 83-90, 1997.
16. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270(5240): 1326-31, 1995.
17. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM and Force T: The stress activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 269(42): 26546-51, 1994.
18. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J and Woodgett JR: The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369(6476): 156-60, 1994.
19. Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ and Verheij M: Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res 59(10): 2457-63, 1999.
20. Amato SF, Swart JM, Berg M, Wanebo HJ, Mehta SR and Chiles TC: Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res 58(2): 241-7, 1998.
21. Flamigni F, Facchini A, Capanni C, Stefanelli C, Tantini B and Caldarera CM: p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem J 341 (Pt 2): 363-9, 1999.
22. Flamigni F, Facchini A, Giordano E, Tantini B and Stefanelli C: Signaling pathways leading to the induction of ornithine decarboxylase: opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors. Biochem Pharmacol 61(1): 25-32, 2001.
23. Liu, GT, Zhang TM, Wang BE and Wang YW: Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol 43: 147-52, 1992.
24. Watanabe K, Hayashi H and Mori Y: Effect of a benzylidene derivative, novel antirheumatic agent, on the production of tissue inhibitor of metalloproteinases. Biol Pharm Bull 17: 58-61, 1994.
25. Nishimura M, Umeda M, Kusanagi A, Urakabe R, Yukimatsu K and Otawara S: Antiproliferative activity of protocatechualdehyde on Chinese hamster cells grown in culture. Gann 72: 868-79, 1981.
26. Nishimura M, Umeda M, Kusanagi A, Urakabe R, Yukimatsu K and Otawara S: Cytomorphological study of cultured mammalian cells treated with benzaldehyde, catechol and their derivatives with special reference to inhibition of DNA synthesis. Gann 72: 272-9, 1981.
27. Wick MM and FitzGerald GB: Antitumor effects of biologic reducing agents related to 3,4- dihydroxybenzylamine: dihydroxybenzaldehyde, dihydroxybenzaldoxime, and dihydroxybenzonitrile. J Pharm Sci 76: 513-5, 1987.
28. FitzGerald GB and Wick MM: Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamine. Biochem Pharmacol 34: 353-60,1985.
29. Fitzgerald GB and Wick MM: Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes. Biochem Pharmacol 35: 271-5, 1986.
30. Wang Y, Hasuma T, Yano Y, Morishima Y, Matsui-Yuasa I and Otani S: Induction of apoptosis in CTLL-2 cells by protocatechualdehyde. Anticancer Res 21(24): 1095-101, 2001.
31. Gillis S, Baker PE, Ruscetti FW and Smith KA: Long-term culture of human antigen-specific cytotoxic T-cell lines. J Exp Med 148(4): 1093-8, 1978.
32. Otani S, Kuramoto A, Matsui I and Morisawa S: Induction of ornithine decarboxylase in guinea pig lymphocytes by the divalent cation ionophore A 23187. Effect of dibutyryladenosine 3′,5′-monophosphate. Eur J Biochem 125(1): 35-40, 1982.
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(259): 680-5, 1970.
34. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1): 156-9, 1987.
35. Kahana C and Nathans D: Isolation of cloned cDNA encoding mammalian ornithine decarboxylase. Proc Natl Acad Sci USA 81(12): 3645-9, 1984.
36. Smith CA, Williams GT, Kingston R, Jenkinson EJ and Owen JJ: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337(6203): 181-4, 1989.
37. Parchment RE: Programmed cell death (apoptosis) in murine blastocysts: extracellular free radicals, polyamines, and other cytotoxic agents. In Vivo 5(5): 493-500, 1991.
38. Pegg AE: Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234(2): 249-62, 1986.
39. Packham G and Cleveland JL: Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 14(9): 5741-7, 1994.
40. Sjoerdsma A and Schechter PJ: Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin Pharmacol Ther 35(3): 287-300, 1984.
41. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48(4): 759-74, 1988.
42. Vrana JA, Grant S and Dent P: Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation. Radiat Res 151(5): 559-69, 1999.
43. Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R and Dent P: Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 16(21): 2787-96, 1998.
44. Jarvis WD, Fornari FA, Jr., Auer KL, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent P and Grant S: Coordinate regulation of stress-and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol 52(6): 935-47, 1997.
45. Manni A, Wechter R, Gilmour S, Verderame MF, Mauger D and Demers LM: Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage independent growth of human breast epithelial cells. Int J Cancer 70(2): 175-82, 1997.